Evolus (EOLS) Total Liabilities (2017 - 2026)
Evolus (EOLS) reported Total Liabilities of $249.4 million for Q1 2026, up 13.39% on a YoY basis from $220.0 million in Q1 2025, and little changed quarter-over-quarter from $249.0 million in Q4 2025.
Evolus (EOLS) Total Liabilities (2017 - 2026) Analysis & Trends
Evolus has reported Total Liabilities for 10 years, with the latest figure at $249.4 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities rose 13.39% year-over-year to $249.4 million; the trailing twelve-month figure through Mar 2026 stood at $249.4 million (up 13.39% YoY), and the FY2025 full-year result was $249.0 million, up 9.66% from the prior year.
- Total Liabilities for Q1 2026 stood at $249.4 million, roughly flat from $249.0 million in the prior quarter.
- The five-year high for Total Liabilities was $249.4 million in Q1 2026, with the low at $153.3 million in Q1 2023.
- Historically, Total Liabilities has averaged $203.1 million across 5 years, with a median of $209.7 million in 2023.
- The largest YoY upside for Total Liabilities was 38.77% in 2022 against a maximum downside of 9.18% in 2022.
- Evolus' Total Liabilities stood at $159.5 million in 2022, then soared by 31.48% to $209.7 million in 2023, then grew by 8.28% to $227.0 million in 2024, then gained by 9.66% to $249.0 million in 2025, then climbed by 0.18% to $249.4 million in 2026.
- The last three Total Liabilities figures came in at $249.4 million (Q1 2026), $249.0 million (Q4 2025), and $247.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 31.81 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 11.92 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 813.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 148.77 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 1.50 Bn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 6.72 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 2.51 Bn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 1.13 Bn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 1.82 Bn |
| 10 | Evolus | 435.45 Mn | 385.65 Mn | 48.90 Mn | 249.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 249.43 Mn |
| Dec 31, 2025 | 248.97 Mn |
| Sep 30, 2025 | 247.76 Mn |
| Jun 30, 2025 | 247.46 Mn |
| Mar 31, 2025 | 219.97 Mn |
| Dec 31, 2024 | 227.05 Mn |
| Sep 30, 2024 | 223.72 Mn |
| Jun 30, 2024 | 214.46 Mn |
| Mar 31, 2024 | 207.73 Mn |
| Dec 31, 2023 | 209.69 Mn |
| Sep 30, 2023 | 187.34 Mn |
| Jun 30, 2023 | 175.95 Mn |
| Mar 31, 2023 | 153.29 Mn |
| Dec 31, 2022 | 159.48 Mn |
| Sep 30, 2022 | 163.50 Mn |
| Jun 30, 2022 | 164.06 Mn |
| Mar 31, 2022 | 153.41 Mn |
| Dec 31, 2021 | 175.61 Mn |
| Sep 30, 2021 | 117.82 Mn |
| Jun 30, 2021 | 133.73 Mn |